secwatch.observer — SEC 8-K summary
======================================

Issuer:     T2 Biosystems, Inc. (—)
CIK:        0001492674
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001193125-23-087983
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

T2 Biosystems receives Nasdaq deficiency notice for bid price below $1.00
-------------------------------------------------------------------------

- Nasdaq letter dated March 30, 2023 cites bid price below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until September 26, 2023, to regain compliance.
- Compliance requires closing at $1.00 or more for at least ten consecutive business days.
- Company may seek an additional 180-day cure period if it meets other initial listing standards.
- Management evaluating options including a potential reverse stock split to cure the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1492674/000119312523087983/0001193125-23-087983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1492674/000119312523087983/d468341d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-087983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer